BioCryst Pharmaceuticals Form 4 Filings Shows CCO Charles K Gayer Bought 30,000 Shares At An Average Price Of $5.47/Share; CEO Jon P Stonehouse Bought 30,000 Shares At An Average Price Of $5.55/Share; Steven K Galson Bought 21,940 Shares At An Average...
BioCryst Pharmaceuticals Form 4 Filings Shows CCO Charles K Gayer Bought 30,000 Shares At An Average Price Of $5.47/Share; CEO Jon P Stonehouse Bought 30,000 Shares At An Average Price Of $5.55/Share; Steven K Galson Bought 21,940 Shares At An Average...
BioCryst Pharmicals表格4文件顯示，首席運營官查爾斯·蓋爾以平均每股5.47美元的價格購買了3萬股股票；首席執行官喬恩·斯通豪斯以每股5.55美元的平均價格購買了3萬股股票；史蒂芬·加爾森平均購買了21,940股股票...
BioCryst Pharmaceuticals Form 4 Filings Shows CCO Charles K Gayer Bought 30,000 Shares At An Average Price Of $5.47/Share; CEO Jon P Stonehouse Bought 30,000 Shares At An Average Price Of $5.55/Share; Steven K Galson Bought 21,940 Shares At An Average Price Of $5.49/Share; Helen M. Thackray Bought 30,000 Shares At An Average Price Of $5.86/Share; Anthony Doyle Bought 36,300 Shares At An Average Price Of $5.57/Share
BioCryst Pharmicals表格4文件顯示，首席運營官查爾斯·蓋爾以平均每股5.47美元的價格購買了3萬股股票；首席執行官喬恩·斯通豪斯以每股5.55美元的平均價格購買了3萬股股票；史蒂芬·加爾森以平均每股5.49美元的價格購買了21,940股股票；海倫·薩克雷以每股5.86美元的平均價格購買了3萬股股票；安東尼·道爾購買了36,300股股票平均價格爲每股5.57美元
- SEC Filing
-美國證券交易委員會備案